Mostra el registre d'ítem simple
Benzocaine polymorphism: Pressure-temperature phase diagram involving forms II and III
dc.contributor.author | Gana, Inès |
dc.contributor.author | Barrio Casado, María del |
dc.contributor.author | Do, Bernard |
dc.contributor.author | Tamarit Mur, José Luis |
dc.contributor.author | Céolin, René |
dc.contributor.author | Rietveld, Ivo B. |
dc.contributor.other | Universitat Politècnica de Catalunya. Departament de Física i Enginyeria Nuclear |
dc.date.accessioned | 2014-01-19T12:57:06Z |
dc.date.created | 2013-11-18 |
dc.date.issued | 2013-11-18 |
dc.identifier.citation | Gana, I. [et al.]. Benzocaine polymorphism: Pressure-temperature phase diagram involving forms II and III. "International journal of pharmaceutics", 18 Novembre 2013, vol. 456, núm. 2, p. 480-488. |
dc.identifier.issn | 0378-5173 |
dc.identifier.uri | http://hdl.handle.net/2117/21276 |
dc.description.abstract | tUnderstanding the phase behavior of an active pharmaceutical ingredient in a drug formulation isrequired to avoid the occurrence of sudden phase changes resulting in decrease of bioavailability in amarketed product. Benzocaine is known to possess three crystalline polymorphs, but their stability hier-archy has so far not been determined. A topological method and direct calorimetric measurements underpressure have been used to construct the topological pressure–temperature diagram of the phase rela-tionships between the solid phases II and III, the liquid, and the vapor phase. In the process, the transitiontemperature between solid phases III and II and its enthalpy change have been determined. Solid phaseII, which has the highest melting point, is the more stable phase under ambient conditions in this phasediagram. Surprisingly, solid phase I has not been observed during the study, even though the scarce lit-erature data on its thermal behavior appear to indicate that it might be the most stable one of the threesolid phases. |
dc.format.extent | 9 p. |
dc.language.iso | eng |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 Spain |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/es/ |
dc.subject | Àrees temàtiques de la UPC::Ciències de la salut::Medicina::Farmacologia |
dc.subject | Àrees temàtiques de la UPC::Física::Termodinàmica |
dc.subject.lcsh | Pharmaceutical industry |
dc.subject.lcsh | Thermodynamics |
dc.subject.other | Phase diagram |
dc.subject.other | Physical stability |
dc.subject.other | Polymorphism |
dc.subject.other | Pressure |
dc.subject.other | Thermodynamics |
dc.subject.other | X-ray powder diffraction |
dc.title | Benzocaine polymorphism: Pressure-temperature phase diagram involving forms II and III |
dc.type | Article |
dc.subject.lemac | Indústria farmacèutica |
dc.subject.lemac | Termodinàmica |
dc.contributor.group | Universitat Politècnica de Catalunya. GCM - Grup de Caracterització de Materials |
dc.identifier.doi | 10.1016/j.ijpharm.2013.08.031 |
dc.relation.publisherversion | http://www.sciencedirect.com/science/article/pii/S0378517313007643 |
dc.rights.access | Restricted access - publisher's policy |
local.identifier.drac | 12898777 |
dc.description.version | Postprint (published version) |
dc.date.lift | 10000-01-01 |
local.citation.author | Gana, I.; Del Barrio, M.; Do, B.; Tamarit, J.; Céolin, R.; Rietveld, I.R. |
local.citation.publicationName | International journal of pharmaceutics |
local.citation.volume | 456 |
local.citation.number | 2 |
local.citation.startingPage | 480 |
local.citation.endingPage | 488 |
Fitxers d'aquest items
Aquest ítem apareix a les col·leccions següents
-
Articles de revista [603]
-
Articles de revista [332]